DECITABINE IN COMBINATION WITH DONOR LYMPHOCYTE INFUSION AS SALVAGE THERAPY FOR RELAPSED AML POST-ALLOGENEIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Kritharis, A. [1 ]
Donahue, L. L. [1 ]
Keyzner, A. [1 ]
Devoe, C. [1 ]
Bayer, R. L. [1 ]
机构：
[1] Hofstra Univ, Sch Med, N Shore LIJ Hlth Syst, Lake Success, NY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2011.12.322
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
331
引用
收藏
页码：S327 / S327
页数：1
相关论文
共 50 条
  • [1] Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation
    Kalin, Burak
    van Norden, Yvette
    van Gelder, Michel
    Breems, Dimitri
    Maertens, Johan
    Jongen-Lavrencic, Mojca
    Broers, Annoek E. C.
    Braakman, Eric
    Grob, Tim
    Zeijlemaker, Wendelien
    Ossenkoppele, Gert J.
    Meijer, Ellen
    Cornelissen, Jan J.
    BLOOD ADVANCES, 2020, 4 (18) : 4430 - 4437
  • [2] Salvage chemotherapy and donor lymphocyte infusion induces durable remissions in AML relapsing following allogeneic stem cell transplantation
    Lubowiecki, Marcin
    Balassa, Katalin
    Watson, Edmund
    Cash, Rebecca
    Barton, Daja
    Ellis, Mandy
    Rowley, Lara
    Wareham, Denise
    Costa, Claudia
    Miller, Rachel
    Pawson, Rachel
    Hamblin, Angela
    Quek, Lynn
    Vyas, Paresh
    Rocha, Vanderson
    Peniket, Andy
    Danby, Robert
    BONE MARROW TRANSPLANTATION, 2018, 53 : 184 - 185
  • [3] Single Center Experience with the Use of Hypomethylating Agents in Combination with Donor Lymphocyte Infusions As Initial Salvage Therapy Post Allogeneic Stem Cell Transplant in Relapsed AML/MDS/MPN
    Welch, Renee
    Minor, Kerry King
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S384 - S385
  • [4] Donor lymphocyte infusion after salvage chemotherapy in relapsed acute myeloblastic leukemia patients after allogeneic stem cell transplantation
    Uslu, Atilla
    Seval, Guldane Cengiz
    Bozdag, Sinem Civriz
    Gurman, Gunhan
    Demirer, Taner
    Arslan, Onder
    Ozcan, Muhit
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Ilhan, Osman
    BONE MARROW TRANSPLANTATION, 2018, 53 : 161 - 162
  • [5] Rituximab-bendamustine prior to donor lymphocyte infusion as salvage treatment in Hodgkin's disease patients relapsed post allogeneic stem cell transplantation
    Sala, E.
    Ventre, M. Bruno
    Messina, C.
    Tassara, M.
    Crotta, A.
    Levati, G.
    Guggiari, E.
    Marktel, S.
    Assanelli, A.
    Peccatori, J.
    Bernardi, M.
    Ciceri, F.
    Corti, C.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S442 - S443
  • [6] Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    Schroeder, T.
    Czibere, A.
    Platzbecker, U.
    Bug, G.
    Uharek, L.
    Luft, T.
    Giagounidis, A.
    Zohren, F.
    Bruns, I.
    Wolschke, C.
    Rieger, K.
    Fenk, R.
    Germing, U.
    Haas, R.
    Kroeger, N.
    Kobbe, G.
    LEUKEMIA, 2013, 27 (06) : 1229 - 1235
  • [7] Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    T Schroeder
    A Czibere
    U Platzbecker
    G Bug
    L Uharek
    T Luft
    A Giagounidis
    F Zohren
    I Bruns
    C Wolschke
    K Rieger
    R Fenk
    U Germing
    R Haas
    N Kröger
    G Kobbe
    Leukemia, 2013, 27 : 1229 - 1235
  • [8] Immunomodulation by escalated lymphodepletion and donor lymphocyte infusion to treat post-allogeneic transplantation relapse
    Guillaume, T.
    Gaugler, B.
    Chevallier, P.
    Delaunay, J.
    Ayari, S.
    Moreau, P.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S319 - S320
  • [9] Donor lymphocyte infusion after allogeneic stem cell transplantation
    Castagna, Luca
    Sarina, Barbara
    Bramanti, Stefania
    Perseghin, Paolo
    Mariotti, Jacopo
    Morabito, Lucio
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (03) : 345 - 355
  • [10] Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation
    Ito, Sawa
    Krakow, Elizabeth F.
    Ventura, Kedwin
    Rodger, Amy
    Geramita, Emily
    Moore, Erika
    Hill, Geoffrey R.
    Shlomchik, Warren D.
    BLOOD, 2022, 140 : 7678 - 7679
12345